Emerging for non-invasive heparin delivery systems: recent advances, barriers, solutions, and applicability
Author:
Open Access
- 12 June 2025
- journal article
- review article
- Published by Springer Nature in Saudi Pharmaceutical Journal
- Vol. 33 (3) , 1-17
Abstract
Nowadays, the use of unfractionated low molecular weight heparins through intravenous and subcutaneous routes has been limited by several delivery challenges. These include pharmacological activity fluctuations, bleeding issues, and numerous manufacturing restrictions. To address these issues, several efforts have been taken to find alternative routes for this medication. Unfortunately, the past and recent reviews were mainly explored the oral dosage forms of heparin and the other possible indications in practice. This review focuses on emerging efficient and non-invasive heparin options such as buccal, sublingual, oral, rectal and vaginal, transdermal, pulmonary and nasal. To do that, the past and recent studies were categorized into three main groups: (1) Conventional invasive heparin delivery methods; (2) Novel non-invasive heparin delivery systems; and (3) Heparin-based nanoparticles. The main challenges to use non-invasive heparin delivery systems were found to be negative charge and high molecular weight of heparin. Besides, the biological, biophysical, and pharmacological constraints could also limit the benefits of these alternatives. To overcome these issues, the following mechanisms have been used to enhance the delivery of heparin through several routes: (1) Improvement of cell-membrane penetration, (2) Changing of the tight-junctions, (3) Promoting the lipophilicity and (4) Preserving against acidic pH of the stomach. The applicability of alternative delivery options for heparin was mainly affected by overcoming the main penetration barriers. Nanoparticles were found to be effective in increasing the permeability, absorption, bioavailability and bioactivity of heparin.Keywords
This publication has 118 references indexed in Scilit:
- Peptide‐Based Organic‐Inorganic Hybrid Self‐Assemblies for Ultrasensitive and Visual Detection of HeparinAdvanced Functional Materials, 2023
- Direct Oral Anticoagulants vs Low-Molecular-Weight Heparin and Recurrent VTE in Patients With CancerJAMA, 2023
- Clinical use of low-dose parenteral anticoagulation, incidence of major bleeding and mortality: a multi-centre cohort study using the French national health data systemEuropean Journal of Clinical Pharmacology, 2022
- Buccal Delivery of Nanoparticles2020
- Nanoparticles for Detection and Treatment of Peripheral Arterial DiseaseSmall, 2018
- Novel mineralized heparin–gelatin nanoparticles for potential application in tissue engineering of boneJournal of Materials Science: Materials in Medicine, 2013
- Heparinized Magnetic Nanoparticles: In‐Vitro Assessment for Biomedical ApplicationsAdvanced Functional Materials, 2006
- Nasal administration of low molecular weight heparinJournal of Pharmaceutical Sciences, 2002
- Heparin Alters Transdermal Transport Associated with ElectroporationBiochemical and Biophysical Research Communications, 1997
- BUCCAL AND SUBLINGUAL ADMINISTRATION OF HEPARIN POTASSIUM (CLARIN)JAMA, 1959